“…We recommend not to use local administration of statin gels (atorvastatin, simvastatin, rosuvastatin) as adjuncts to subgingival instrumentation.Supporting literatureDonos et al (2019) Quality of evidence Twelve placebo-controlled RCTs (n = 753), for 1.2% atorvastatin (six RCTs, n = 180), 1.2% simvastatin gel (5 RCTs, n = 118) and 1.2% rosuvastatin gel (four RCTs, n = 122)Grade of recommendation Grade A-↓↓Strength of consensus Strong consensus (0% of the group abstained due to potential CoI)BackgroundInterventionStatins are known to have pleiotropic pharmacological effects in addition to their hypolipidemic properties. These include antioxidant and anti-inflammatory effects, the stimulation of angiogenesis, improvements in endothelial function and the positive regulation of bone formation pathways(Adam & Laufs, 2008;Mennickent, Bravo, Calvo, & Avello, 2008;Petit et al, 2019).Recent evidence suggests that statins may also attenuate periodontal inflammation, as reflected by decreases in pro-inflammatory and increases in anti-inflammatory mediators within the gingival crevicular fluid (GCF) of patients with periodontitis(Cicek Ari et al, 2016).…”